Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 PDE10A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00227 Aminophylline 1件: 63
2 PDE10A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00371 Theophylline 2件: 236, 299
3 PDE10A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D06103 Theophylline 2件: 236, 299
4 PDE10A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07546 Bucladesine 1件: 246
5 PDE10A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07961 Flavoxate 1件: 226
6 CA5B 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
7 CA5B 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
8 CA5B 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
9 TPH2 3件: Tryptophan metabolism, Metabolic pathways, Serotonergic synapse D09973 Telotristat 1件: 97
10 ADH1A 5件: Tyrosine metabolism, Pyruvate metabolism, Retinol metabolism, Metabolism of xenobiotics by cytochrome P450, Metabolic pathways D00707 Fomepizole 1件: 301
11 ADH1B 5件: Tyrosine metabolism, Pyruvate metabolism, Retinol metabolism, Metabolism of xenobiotics by cytochrome P450, Metabolic pathways D00707 Fomepizole 1件: 301
12 ADH1C 5件: Tyrosine metabolism, Pyruvate metabolism, Retinol metabolism, Metabolism of xenobiotics by cytochrome P450, Metabolic pathways D00707 Fomepizole 1件: 301
13 COMT 3件: Steroid hormone biosynthesis, Tyrosine metabolism, Metabolic pathways D00781 Entacapone 2件: 6, 17
14 COMT 3件: Steroid hormone biosynthesis, Tyrosine metabolism, Metabolic pathways D00786 Tolcapone 3件: 6, 28, 127
15 COMT 3件: Steroid hormone biosynthesis, Tyrosine metabolism, Metabolic pathways D10825 Opicapone 1件: 6
16 CPS1 2件: Nitrogen metabolism, Metabolic pathways D07130 Carglumic acid 3件: 245, 246, 251
17 CYP11A1 3件: Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis D10950 Levoketoconazole 1件: 75
18 CYP11B1 2件: Steroid hormone biosynthesis, Metabolic pathways D00410 Metyrapone 1件: 75
19 CYP11B1 2件: Steroid hormone biosynthesis, Metabolic pathways D10950 Levoketoconazole 1件: 75
20 CYP11B2 2件: Steroid hormone biosynthesis, Metabolic pathways D11061 Osilodrostat 1件: 75
21 CYP17A1 4件: Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway D00351 Ketoconazole 3件: 8, 13, 75
22 CYP17A1 4件: Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway D10950 Levoketoconazole 1件: 75
23 CYP19A1 3件: Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis D00960 Anastrozole 3件: 78, 86, 193
24 CYP19A1 3件: Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis D00964 Letrozole 2件: 81, 89
25 DDC 5件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse D00558 Carbidopa 7件: 6, 13, 17, 90, 140, 164, 201
26 DDC 5件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse D03082 Benserazide 1件: 6
27 DHFR 2件: One carbon pool by folate, Metabolic pathways D00142 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331
28 DHODH 2件: Pyrimidine metabolism, Metabolic pathways D00749 Leflunomide 12件: 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300
29 DHODH 2件: Pyrimidine metabolism, Metabolic pathways D10172 Teriflunomide 3件: 13, 25, 26
30 NQO1 3件: Ubiquinone and other terpenoid-quinone biosynthesis, Metabolic pathways, Pathways in cancer D08682 Warfarin 11件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91
31 DNMT1 2件: Metabolic pathways, MicroRNAs in cancer D03665 Decitabine 3件: 13, 60, 63
32 DNMT3A 2件: Metabolic pathways, MicroRNAs in cancer D03665 Decitabine 3件: 13, 60, 63
33 DNMT3B 2件: Metabolic pathways, MicroRNAs in cancer D03665 Decitabine 3件: 13, 60, 63
34 ABAT 3件: Valine, leucine and isoleucine degradation, Propanoate metabolism, Metabolic pathways D00399 Valproic acid 14件: 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256
35 ABAT 3件: Valine, leucine and isoleucine degradation, Propanoate metabolism, Metabolic pathways D00535 Vigabatrin 2件: 145, 158
36 DHFR2 2件: One carbon pool by folate, Metabolic pathways D00142 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331
37 ALAS1 2件: Porphyrin metabolism, Metabolic pathways D10003 Hemin 1件: 254
38 ALAS1 2件: Porphyrin metabolism, Metabolic pathways D11702 Givosiran 1件: 254
39 ALAS2 2件: Porphyrin metabolism, Metabolic pathways D10003 Hemin 1件: 254
40 FDPS 2件: Terpenoid backbone biosynthesis, Metabolic pathways D01968 Zoledronic acid 13件: 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333
41 FDPS 2件: Terpenoid backbone biosynthesis, Metabolic pathways D07119 Alendronic acid 7件: 19, 41, 46, 50, 271, 274, 299
42 FDPS 2件: Terpenoid backbone biosynthesis, Metabolic pathways D07281 Pamidronic acid 3件: 270, 271, 274
43 FDPS 2件: Terpenoid backbone biosynthesis, Metabolic pathways D08484 Risedronic acid 9件: 46, 50, 66, 93, 95, 96, 107, 113, 274
44 FDPS 2件: Terpenoid backbone biosynthesis, Metabolic pathways D08689 Zoledronic acid 13件: 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333
45 CA14 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
46 CA14 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
47 CA14 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
48 ALOX5 4件: Metabolic pathways, Serotonergic synapse, Ovarian steroidogenesis, Toxoplasmosis D00414 Zileuton 3件: 85, 160, 164
49 ALOX5 4件: Metabolic pathways, Serotonergic synapse, Ovarian steroidogenesis, Toxoplasmosis D01773 Oxatomide 1件: 113
50 ALPL 2件: Thiamine metabolism, Metabolic pathways D10595 Asfotase alfa 1件: 172
51 GAA 2件: Starch and sucrose metabolism, Metabolic pathways D00216 Acarbose 1件: 298
52 GAA 2件: Starch and sucrose metabolism, Metabolic pathways D03207 Alglucosidase alfa 1件: 256
53 GAA 2件: Starch and sucrose metabolism, Metabolic pathways D09605 Duvoglustat 1件: 256
54 GAA 2件: Starch and sucrose metabolism, Metabolic pathways D11744 Avalglucosidase alfa 1件: 256
55 GAA 2件: Starch and sucrose metabolism, Metabolic pathways D11798 Cipaglucosidase alfa 1件: 256
56 GAD1 3件: Taurine and hypotaurine metabolism, Metabolic pathways, Type I diabetes mellitus D00399 Valproic acid 14件: 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256
57 GAD2 3件: Taurine and hypotaurine metabolism, Metabolic pathways, Type I diabetes mellitus D00399 Valproic acid 14件: 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256
58 GALNS 1件: Metabolic pathways D10333 Elosulfase alfa 1件: 19
59 GANC 2件: Starch and sucrose metabolism, Metabolic pathways D00216 Acarbose 1件: 298
60 GBA1 3件: Other glycan degradation, Sphingolipid metabolism, Metabolic pathways D02810 Alglucerase 1件: 19
61 GBA1 3件: Other glycan degradation, Sphingolipid metabolism, Metabolic pathways D03020 Imiglucerase 1件: 19
62 GBA1 3件: Other glycan degradation, Sphingolipid metabolism, Metabolic pathways D09029 Velaglucerase alfa 1件: 19
63 GBA1 3件: Other glycan degradation, Sphingolipid metabolism, Metabolic pathways D09675 Taliglucerase alfa 1件: 19
64 PDE7B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00227 Aminophylline 1件: 63
65 PDE7B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00371 Theophylline 2件: 236, 299
66 PDE7B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D06103 Theophylline 2件: 236, 299
67 PDE7B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07546 Bucladesine 1件: 246
68 PDE7B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07961 Flavoxate 1件: 226
69 GLA 2件: Sphingolipid metabolism, Metabolic pathways D02784 Agalsidase alfa 1件: 19
70 GLA 2件: Sphingolipid metabolism, Metabolic pathways D03228 Agalsidase beta 1件: 19
71 AMY2A 4件: Starch and sucrose metabolism, Metabolic pathways, Salivary secretion, Pancreatic secretion D00216 Acarbose 1件: 298
72 AMY2B 4件: Starch and sucrose metabolism, Metabolic pathways, Salivary secretion, Pancreatic secretion D00216 Acarbose 1件: 298
73 ANPEP 2件: Metabolic pathways, Renin-angiotensin system D00087 Ubenimex 1件: 86
74 GUCY1A2 7件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion D00517 Amyl Nitrite 1件: 58
75 GUCY1A2 7件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion D09572 Riociguat 6件: 51, 84, 86, 88, 225, 299
76 GUCY1A1 7件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion D00517 Amyl Nitrite 1件: 58
77 GUCY1A1 7件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion D09572 Riociguat 6件: 51, 84, 86, 88, 225, 299
78 GUCY1B1 7件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion D00517 Amyl Nitrite 1件: 58
79 GUCY1B1 7件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Platelet activation, Oxytocin signaling pathway, Renin secretion, Salivary secretion D09572 Riociguat 6件: 51, 84, 86, 88, 225, 299
80 GUCY2C 2件: Purine metabolism, Metabolic pathways D09355 Linaclotide 2件: 6, 97
81 GUSB 3件: Pentose and glucuronate interconversions, Porphyrin metabolism, Metabolic pathways D11004 Vestronidase alfa 1件: 19
82 HMGCR 2件: Terpenoid backbone biosynthesis, Metabolic pathways D00359 Lovastatin 11件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310
83 HMGCR 2件: Terpenoid backbone biosynthesis, Metabolic pathways D00434 Simvastatin 21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
84 HMGCR 2件: Terpenoid backbone biosynthesis, Metabolic pathways D07474 Atorvastatin 19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299
85 HMGCR 2件: Terpenoid backbone biosynthesis, Metabolic pathways D07983 Fluvastatin 3件: 79, 218, 222
86 HMGCR 2件: Terpenoid backbone biosynthesis, Metabolic pathways D08410 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333
87 HMGCR 2件: Terpenoid backbone biosynthesis, Metabolic pathways D08492 Rosuvastatin 11件: 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299
88 HMOX1 5件: Porphyrin metabolism, Metabolic pathways, Mineral absorption, Pathways in cancer, MicroRNAs in cancer D05922 Stannsoporfin 1件: 254
89 HMOX2 3件: Porphyrin metabolism, Metabolic pathways, Mineral absorption D05922 Stannsoporfin 1件: 254
90 HPD 4件: Ubiquinone and other terpenoid-quinone biosynthesis, Tyrosine metabolism, Phenylalanine metabolism, Metabolic pathways D05177 Nitisinone 3件: 6, 164, 241
91 HPRT1 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D00161 Mercaptopurine 4件: 65, 96, 97, 164
92 HPRT1 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D04931 Mercaptopurine 4件: 65, 96, 97, 164
93 HPRT1 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D08603 Tioguanine 2件: 13, 37
94 IDS 1件: Metabolic pathways D04499 Idursulfase 1件: 19
95 IDS 1件: Metabolic pathways D11025 Idursulfase beta 1件: 19
96 IDS 1件: Metabolic pathways D11812 Pabinafusp alfa 1件: 19
97 IDUA 1件: Metabolic pathways D04670 Laronidase 2件: 19, 256
98 IMPDH1 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D00752 Mycophenolate mofetil 34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300
99 IMPDH1 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D01392 Mizoribine 8件: 46, 49, 51, 53, 66, 94, 222, 224
100 IMPDH1 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D05096 Mycophenolic acid 36件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300
101 IMPDH2 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D00752 Mycophenolate mofetil 34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300
102 IMPDH2 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D01392 Mizoribine 8件: 46, 49, 51, 53, 66, 94, 222, 224
103 IMPDH2 3件: Purine metabolism, Metabolic pathways, Nucleotide metabolism D05096 Mycophenolic acid 36件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300
104 CA13 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
105 CA13 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
106 CA13 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
107 ARSB 1件: Metabolic pathways D06565 Galsulfase 1件: 19
108 MAOA 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D02561 Moclobemide 1件: 6
109 MAOA 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D02579 Iproniazid 1件: 6
110 MAOA 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D05458 Phentermine 1件: 97
111 MAOA 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D08349 Phenelzine 1件: 6
112 MAOB 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D02579 Iproniazid 1件: 6
113 MAOB 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D03731 Selegiline 1件: 6
114 MAOB 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D05458 Phentermine 1件: 97
115 MAOB 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D08349 Phenelzine 1件: 6
116 MAOB 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D08469 Rasagiline 6件: 2, 5, 6, 17, 58, 66
117 MAOB 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D10158 Safinamide 2件: 6, 17
118 MAOB 6件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Parkinson disease D10829 Rasagiline 6件: 2, 5, 6, 17, 58, 66
119 NPR1 7件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Thermogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion D04051 Erythrityl tetranitrate 1件: 46
120 NPR1 7件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Thermogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion D05147 Nesiritide 2件: 46, 58
121 NPR2 4件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Oxytocin signaling pathway D04051 Erythrityl tetranitrate 1件: 46
122 NPR2 4件: Purine metabolism, Metabolic pathways, Vascular smooth muscle contraction, Oxytocin signaling pathway D11190 Vosoritide 1件: 276
123 ODC1 1件: Metabolic pathways D07883 Eflornithine 1件: 65
124 ATP4A 2件: Oxidative phosphorylation, Metabolic pathways D00355 Lansoprazole 7件: 63, 71, 85, 98, 166, 222, 299
125 ATP4A 2件: Oxidative phosphorylation, Metabolic pathways D00455 Omeprazole 14件: 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299
126 ATP4A 2件: Oxidative phosphorylation, Metabolic pathways D05353 Pantoprazole 2件: 13, 65
127 ATP4A 2件: Oxidative phosphorylation, Metabolic pathways D07917 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299
128 ATP4A 2件: Oxidative phosphorylation, Metabolic pathways D08463 Rabeprazole 2件: 2, 51
129 ATP4A 2件: Oxidative phosphorylation, Metabolic pathways D08903 Dexlansoprazole 1件: 98
130 ATP4A 2件: Oxidative phosphorylation, Metabolic pathways D11784 Vonoprazan 2件: 63, 98
131 ATP4B 2件: Oxidative phosphorylation, Metabolic pathways D00355 Lansoprazole 7件: 63, 71, 85, 98, 166, 222, 299
132 ATP4B 2件: Oxidative phosphorylation, Metabolic pathways D00455 Omeprazole 14件: 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299
133 ATP4B 2件: Oxidative phosphorylation, Metabolic pathways D05353 Pantoprazole 2件: 13, 65
134 ATP4B 2件: Oxidative phosphorylation, Metabolic pathways D07917 Esomeprazole 8件: 13, 46, 86, 98, 107, 113, 298, 299
135 ATP4B 2件: Oxidative phosphorylation, Metabolic pathways D08463 Rabeprazole 2件: 2, 51
136 ATP4B 2件: Oxidative phosphorylation, Metabolic pathways D08903 Dexlansoprazole 1件: 98
137 ATP4B 2件: Oxidative phosphorylation, Metabolic pathways D11784 Vonoprazan 2件: 63, 98
138 PAH 3件: Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis, Metabolic pathways D11077 Pegvaliase 1件: 240
139 PDE11A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00227 Aminophylline 1件: 63
140 PDE11A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00371 Theophylline 2件: 236, 299
141 PDE11A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D06103 Theophylline 2件: 236, 299
142 PDE11A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07546 Bucladesine 1件: 246
143 PDE11A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07961 Flavoxate 1件: 226
144 PDE1A 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D00227 Aminophylline 1件: 63
145 PDE1A 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D00371 Theophylline 2件: 236, 299
146 PDE1A 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D06103 Theophylline 2件: 236, 299
147 PDE1A 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D07546 Bucladesine 1件: 246
148 PDE1A 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D07961 Flavoxate 1件: 226
149 PDE1C 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D00227 Aminophylline 1件: 63
150 PDE1C 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D00371 Theophylline 2件: 236, 299
151 PDE1C 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D06103 Theophylline 2件: 236, 299
152 PDE1C 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D07546 Bucladesine 1件: 246
153 PDE1C 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D07961 Flavoxate 1件: 226
154 PDE2A 4件: Purine metabolism, Metabolic pathways, Olfactory transduction, Morphine addiction D00227 Aminophylline 1件: 63
155 PDE2A 4件: Purine metabolism, Metabolic pathways, Olfactory transduction, Morphine addiction D00371 Theophylline 2件: 236, 299
156 PDE2A 4件: Purine metabolism, Metabolic pathways, Olfactory transduction, Morphine addiction D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
157 PDE2A 4件: Purine metabolism, Metabolic pathways, Olfactory transduction, Morphine addiction D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
158 PDE2A 4件: Purine metabolism, Metabolic pathways, Olfactory transduction, Morphine addiction D06103 Theophylline 2件: 236, 299
159 PDE2A 4件: Purine metabolism, Metabolic pathways, Olfactory transduction, Morphine addiction D07546 Bucladesine 1件: 246
160 PDE2A 4件: Purine metabolism, Metabolic pathways, Olfactory transduction, Morphine addiction D07961 Flavoxate 1件: 226
161 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D00227 Aminophylline 1件: 63
162 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D00371 Theophylline 2件: 236, 299
163 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D00417 Milrinone 1件: 294
164 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
165 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D01385 Ibudilast 2件: 2, 13
166 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
167 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D01896 Cilostazol 3件: 46, 51, 70
168 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D04720 Levosimendan 1件: 2
169 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D06103 Theophylline 2件: 236, 299
170 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D07546 Bucladesine 1件: 246
171 PDE3A 4件: Purine metabolism, Metabolic pathways, Renin secretion, Morphine addiction D07961 Flavoxate 1件: 226
172 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D00227 Aminophylline 1件: 63
173 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D00371 Theophylline 2件: 236, 299
174 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D00417 Milrinone 1件: 294
175 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
176 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D01385 Ibudilast 2件: 2, 13
177 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
178 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D01896 Cilostazol 3件: 46, 51, 70
179 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D04720 Levosimendan 1件: 2
180 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D06103 Theophylline 2件: 236, 299
181 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D07546 Bucladesine 1件: 246
182 PDE3B 6件: Purine metabolism, Metabolic pathways, Progesterone-mediated oocyte maturation, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction D07961 Flavoxate 1件: 226
183 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00227 Aminophylline 1件: 63
184 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00302 Dipyridamole 6件: 46, 49, 51, 66, 96, 224
185 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00371 Theophylline 2件: 236, 299
186 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
187 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01385 Ibudilast 2件: 2, 13
188 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
189 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01783 Rolipram 2件: 8, 13
190 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D05744 Roflumilast 4件: 84, 97, 206, 299
191 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D06103 Theophylline 2件: 236, 299
192 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D07546 Bucladesine 1件: 246
193 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D07961 Flavoxate 1件: 226
194 PDE4A 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D08860 Apremilast 7件: 46, 50, 56, 97, 107, 162, 271
195 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00227 Aminophylline 1件: 63
196 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00371 Theophylline 2件: 236, 299
197 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
198 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01385 Ibudilast 2件: 2, 13
199 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
200 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01783 Rolipram 2件: 8, 13
201 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D05744 Roflumilast 4件: 84, 97, 206, 299
202 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D06103 Theophylline 2件: 236, 299
203 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D07546 Bucladesine 1件: 246
204 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D07961 Flavoxate 1件: 226
205 PDE4B 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D08860 Apremilast 7件: 46, 50, 56, 97, 107, 162, 271
206 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00227 Aminophylline 1件: 63
207 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00371 Theophylline 2件: 236, 299
208 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
209 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01385 Ibudilast 2件: 2, 13
210 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
211 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01783 Rolipram 2件: 8, 13
212 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D05744 Roflumilast 4件: 84, 97, 206, 299
213 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D06103 Theophylline 2件: 236, 299
214 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D07546 Bucladesine 1件: 246
215 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D07961 Flavoxate 1件: 226
216 PDE4C 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D08860 Apremilast 7件: 46, 50, 56, 97, 107, 162, 271
217 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00227 Aminophylline 1件: 63
218 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00371 Theophylline 2件: 236, 299
219 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
220 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01385 Ibudilast 2件: 2, 13
221 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
222 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D01783 Rolipram 2件: 8, 13
223 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D05744 Roflumilast 4件: 84, 97, 206, 299
224 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D06103 Theophylline 2件: 236, 299
225 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D07546 Bucladesine 1件: 246
226 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D07961 Flavoxate 1件: 226
227 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D08860 Apremilast 7件: 46, 50, 56, 97, 107, 162, 271
228 PDE4D 4件: Purine metabolism, Metabolic pathways, Parathyroid hormone synthesis, secretion and action, Morphine addiction D12173 Zatolmilast 1件: 206
229 PDE7A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00227 Aminophylline 1件: 63
230 PDE7A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00371 Theophylline 2件: 236, 299
231 PDE7A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D06103 Theophylline 2件: 236, 299
232 PDE7A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07546 Bucladesine 1件: 246
233 PDE7A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07961 Flavoxate 1件: 226
234 PDE8A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00227 Aminophylline 1件: 63
235 PDE8A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00371 Theophylline 2件: 236, 299
236 PDE8A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D06103 Theophylline 2件: 236, 299
237 PDE8A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07546 Bucladesine 1件: 246
238 PDE8A 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07961 Flavoxate 1件: 226
239 PDE1B 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D00227 Aminophylline 1件: 63
240 PDE1B 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D00371 Theophylline 2件: 236, 299
241 PDE1B 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
242 PDE1B 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
243 PDE1B 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D06103 Theophylline 2件: 236, 299
244 PDE1B 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D07546 Bucladesine 1件: 246
245 PDE1B 6件: Purine metabolism, Metabolic pathways, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction D07961 Flavoxate 1件: 226
246 ENPP2 1件: Metabolic pathways D11844 Ziritaxestat 2件: 51, 85
247 PIK3CA 42件: Metabolic pathways, Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Neurotrophin signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Small cell lung cancer, Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11011 Alpelisib 1件: 138
248 PIK3CA 42件: Metabolic pathways, Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Neurotrophin signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Small cell lung cancer, Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11158 Leniolisib 2件: 53, 65
249 PIK3CB 42件: Metabolic pathways, Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Neurotrophin signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Small cell lung cancer, Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11158 Leniolisib 2件: 53, 65
250 PIK3CD 42件: Metabolic pathways, Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Neurotrophin signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Small cell lung cancer, Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11158 Leniolisib 2件: 53, 65
251 PIK3CD 42件: Metabolic pathways, Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway, Neurotrophin signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Prostate cancer, Small cell lung cancer, Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11437 Parsaclisib 3件: 35, 53, 61
252 HAO1 2件: Metabolic pathways, Peroxisome D11925 Lumasiran 1件: 234
253 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00109 Acetylsalicylic acid 14件: 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251
254 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00118 Naproxen 4件: 13, 46, 107, 271
255 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00120 Sulindac 1件: 206
256 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00126 Ibuprofen 7件: 13, 46, 65, 107, 113, 271, 299
257 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00132 Ketoprofen 1件: 46
258 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00141 Indomethacin 3件: 225, 271, 298
259 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00217 Acetaminophen 15件: 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337
260 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00330 Flurbiprofen 3件: 13, 21, 46
261 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D00428 Salsalate 1件: 5
262 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D01183 Tolfenamic acid 1件: 5
263 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D01545 Aceclofenac 1件: 46
264 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D07816 Diclofenac 5件: 13, 34, 46, 78, 271
265 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D08104 Ketorolac 2件: 70, 226
266 PTGS1 4件: Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes D08149 Loxoprofen 2件: 46, 271
267 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00109 Acetylsalicylic acid 14件: 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251
268 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00118 Naproxen 4件: 13, 46, 107, 271
269 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00120 Sulindac 1件: 206
270 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00126 Ibuprofen 7件: 13, 46, 65, 107, 113, 271, 299
271 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00130 Diflunisal 1件: 28
272 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00132 Ketoprofen 1件: 46
273 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00141 Indomethacin 3件: 225, 271, 298
274 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00217 Acetaminophen 15件: 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337
275 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00315 Etodolac 1件: 46
276 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00330 Flurbiprofen 3件: 13, 21, 46
277 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00428 Salsalate 1件: 5
278 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00567 Celecoxib 10件: 2, 3, 34, 46, 70, 89, 107, 161, 171, 271
279 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00568 Rofecoxib 1件: 46
280 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D00969 Meloxicam 4件: 46, 49, 271, 296
281 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D01049 Nimesulide 1件: 46
282 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D01183 Tolfenamic acid 1件: 5
283 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D01545 Aceclofenac 1件: 46
284 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D02709 Valdecoxib 1件: 46
285 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D03710 Etoricoxib 2件: 46, 271
286 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D03714 Lumiracoxib 1件: 46
287 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D03716 Parecoxib 2件: 46, 271
288 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D07816 Diclofenac 5件: 13, 34, 46, 78, 271
289 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D08104 Ketorolac 2件: 70, 226
290 PTGS2 13件: Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, MicroRNAs in cancer, Small cell lung cancer D08149 Loxoprofen 2件: 46, 271
291 RRM1 4件: Purine metabolism, Pyrimidine metabolism, Metabolic pathways, Nucleotide metabolism D01370 Cladribine 3件: 11, 13, 94
292 RRM1 4件: Purine metabolism, Pyrimidine metabolism, Metabolic pathways, Nucleotide metabolism D03546 Clofarabine 5件: 19, 20, 60, 234, 326
293 RRM1 4件: Purine metabolism, Pyrimidine metabolism, Metabolic pathways, Nucleotide metabolism D07966 Fludarabine 20件: 11, 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326
294 RRM2 5件: Purine metabolism, Pyrimidine metabolism, Metabolic pathways, Nucleotide metabolism, p53 signaling pathway D00341 Hydroxyurea 8件: 3, 13, 19, 20, 65, 85, 86, 284
295 SMPD1 4件: Sphingolipid metabolism, Metabolic pathways, Sphingolipid signaling pathway, Necroptosis D10820 Olipudase alfa 1件: 19
296 SRD5A1 2件: Steroid hormone biosynthesis, Metabolic pathways D03820 Dutasteride 2件: 1, 2
297 SRD5A2 3件: Steroid hormone biosynthesis, Metabolic pathways, Prostate cancer D00321 Finasteride 1件: 6
298 SRD5A2 3件: Steroid hormone biosynthesis, Metabolic pathways, Prostate cancer D03820 Dutasteride 2件: 1, 2
299 TPH1 3件: Tryptophan metabolism, Metabolic pathways, Serotonergic synapse D09973 Telotristat 1件: 97
300 TPO 3件: Tyrosine metabolism, Metabolic pathways, Thyroid hormone synthesis D00401 Methimazole 1件: 50
301 TYMS 4件: Pyrimidine metabolism, One carbon pool by folate, Metabolic pathways, Nucleotide metabolism D01244 Tegafur 1件: 46
302 UGCG 2件: Sphingolipid metabolism, Metabolic pathways D05032 Miglustat 3件: 19, 256, 299
303 UGCG 2件: Sphingolipid metabolism, Metabolic pathways D09893 Eliglustat 1件: 19
304 UGCG 2件: Sphingolipid metabolism, Metabolic pathways D11439 Lucerastat 1件: 19
305 UGCG 2件: Sphingolipid metabolism, Metabolic pathways D11633 Venglustat 3件: 6, 19, 67
306 XDH 4件: Purine metabolism, Metabolic pathways, Nucleotide metabolism, Peroxisome D00224 Allopurinol 7件: 6, 46, 57, 60, 66, 96, 97
307 XDH 4件: Purine metabolism, Metabolic pathways, Nucleotide metabolism, Peroxisome D01206 Febuxostat 3件: 2, 6, 13
308 CA1 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
309 CA1 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
310 CA1 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
311 CA2 4件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Pancreatic secretion D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
312 CA2 4件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Pancreatic secretion D00518 Diclofenamide 1件: 114
313 CA2 4件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Pancreatic secretion D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
314 CA2 4件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Pancreatic secretion D07871 Dorzolamide 1件: 90
315 CA3 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
316 CA3 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
317 CA3 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
318 CA4 3件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
319 CA4 3件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation D00518 Diclofenamide 1件: 114
320 CA4 3件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
321 CA4 3件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation D07871 Dorzolamide 1件: 90
322 CA5A 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
323 CA5A 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
324 CA5A 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
325 CA6 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
326 CA6 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
327 CA6 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
328 CA7 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
329 CA7 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
330 CA7 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
331 CA8 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
332 CA8 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
333 CA8 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
334 CA9 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
335 CA9 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
336 CA9 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
337 CA12 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
338 CA12 2件: Nitrogen metabolism, Metabolic pathways D00518 Diclofenamide 1件: 114
339 CA12 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
340 VKORC1 2件: Ubiquinone and other terpenoid-quinone biosynthesis, Metabolic pathways D08354 Phenindione 1件: 65
341 VKORC1 2件: Ubiquinone and other terpenoid-quinone biosynthesis, Metabolic pathways D08682 Warfarin 11件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91
342 ALDH5A1 1件: Metabolic pathways D00399 Valproic acid 14件: 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256
343 PDE8B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00227 Aminophylline 1件: 63
344 PDE8B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D00371 Theophylline 2件: 236, 299
345 PDE8B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D06103 Theophylline 2件: 236, 299
346 PDE8B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07546 Bucladesine 1件: 246
347 PDE8B 3件: Purine metabolism, Metabolic pathways, Morphine addiction D07961 Flavoxate 1件: 226
348 AOC3 3件: Tyrosine metabolism, Phenylalanine metabolism, Metabolic pathways D08044 Hydralazine 1件: 67
349 PDE5A 2件: Purine metabolism, Metabolic pathways D00302 Dipyridamole 6件: 46, 49, 51, 66, 96, 224
350 PDE5A 2件: Purine metabolism, Metabolic pathways D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
351 PDE5A 2件: Purine metabolism, Metabolic pathways D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
352 PDE5A 2件: Purine metabolism, Metabolic pathways D02008 Tadalafil 7件: 6, 51, 75, 84, 86, 113, 210
353 PDE5A 2件: Purine metabolism, Metabolic pathways D08514 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
354 PDE5A 2件: Purine metabolism, Metabolic pathways D08668 Vardenafil 3件: 13, 86, 299
355 PDE5A 2件: Purine metabolism, Metabolic pathways D10027 Udenafil 2件: 86, 210
356 MGAM 2件: Starch and sucrose metabolism, Metabolic pathways D00216 Acarbose 1件: 298
357 CD38 5件: Nicotinate and nicotinamide metabolism, Metabolic pathways, Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion D10777 Daratumumab 5件: 13, 28, 48, 49, 63
358 CD38 5件: Nicotinate and nicotinamide metabolism, Metabolic pathways, Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion D11050 Isatuximab 3件: 28, 61, 283
359 CD38 5件: Nicotinate and nicotinamide metabolism, Metabolic pathways, Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion D11945 Mezagitamab 2件: 63, 66
360 PTGES 1件: Metabolic pathways D01545 Aceclofenac 1件: 46